A Randomized, Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and the Tolerability of a Triple Combination of Amlodipine/Losartan/Rosuvastatin in Patients With Comorbid Essential Hypertension and Hyperlipidemia.
Clin Ther
; 39(12): 2366-2379, 2017 Dec.
Article
in En
| MEDLINE
| ID: mdl-29150250
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Amlodipine
/
Losartan
/
Rosuvastatin Calcium
/
Essential Hypertension
/
Hypercholesterolemia
/
Anticholesteremic Agents
/
Antihypertensive Agents
Type of study:
Clinical_trials
/
Etiology_studies
/
Prognostic_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Clin Ther
Year:
2017
Document type:
Article
Affiliation country:
Country of publication: